A UAE-led research initiative has achieved a breakthrough in both medicine and space exploration, unlocking the possibility of sending the first astronaut with diabetes to space.
The findings of the pioneering ‘Suite Ride’ study, conducted aboard the International Space Station (ISS), were revealed at New York’s Times Square and celebrated at the Burjeel Institute for Global Health at NYC. The mission, led by UAE’s Burjeel Holdings in partnership with Axiom Space, concluded that everyday diabetes tools used by millions on Earth — such as continuous glucose monitors (CGMs) and insulin pens — can function effectively in space. This paves the way for astronauts with diabetes, a condition that has historically excluded candidates from space missions.
Recent Comments